STSS Key Statistics, Chart & Performance
The current stock price of STSS is 1.425 USD. In the past month the price decreased by -42.54%. In the past year, price decreased by -98.57%.
STSS Technical Analysis
STSS Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to STSS. STSS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
STSS Financial Highlights
Over the last trailing twelve months STSS reported a non-GAAP Earnings per Share(EPS) of -689.83. The EPS increased by 72.59% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -23.51% | ||
| ROE | -24.09% | ||
| Debt/Equity | 0.02 |
STSS Forecast & Estimates
7 analysts have analysed STSS and the average price target is 22.44 USD. This implies a price increase of 1474.74% is expected in the next year compared to the current price of 1.425.
For the next year, analysts expect an EPS growth of -633.33% and a revenue growth -95.06% for STSS
STSS Ownership
STSS Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| COO | COOPER COS INC/THE | 17.56 | 15.925B | ||
| SOLV | SOLVENTUM CORP | 11.87 | 13.352B | ||
| ALGN | ALIGN TECHNOLOGY INC | 15.68 | 12.601B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 19.29 | 4.721B | ||
| LNTH | LANTHEUS HOLDINGS INC | 11.44 | 4.301B | ||
| ICUI | ICU MEDICAL INC | 18.24 | 3.695B | ||
| HAE | HAEMONETICS CORP/MASS | 11.84 | 3.044B | ||
| XRAY | DENTSPLY SIRONA INC | 7.92 | 2.5B | ||
| NEOG | NEOGEN CORP | 31.7 | 2.301B | ||
| UFPT | UFP TECHNOLOGIES INC | 25.56 | 1.975B |
Related stock screener links
View all stocks in the Health Care Supplies Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About STSS
Company Profile
Sharps Technology, Inc. is a medical device and pharmaceutical packaging company, which engages in the development and manufacturing of innovative drug delivery systems. The company is headquartered in Melville, New York and currently employs 5 full-time employees. The company went IPO on 2022-04-14. The firm is engaged in offering patented smart-safety syringe products to the healthcare industry. The firm's smart safety syringe products, such as Securgard, Sologard, and Sharps Provensa, are ultra-low waste syringes that incorporate both passive and active safety and reuse prevention features. The company Sharps Securegard and Sologard safety syringe product lines incorporate both active and passive safety features and have been designed to address the primary administration concerns with syringe delivery systems, including accidental needlestick injuries, wasted medicine/dead space and reuse prevention. The company also offers products that are designed with specialized copolymer technology to support the prefillable syringe market segment. The company has a manufacturing facility in Hungary and is pursuing plans to expand its manufacturing capacity in the United States.
Company Info
SHARPS TECHNOLOGY INC
105 Maxess Road, Ste. 124
Melville NEW YORK US
Employees: 5
Phone: 15162464000
SHARPS TECHNOLOGY INC / STSS FAQ
What does STSS do?
Sharps Technology, Inc. is a medical device and pharmaceutical packaging company, which engages in the development and manufacturing of innovative drug delivery systems. The company is headquartered in Melville, New York and currently employs 5 full-time employees. The company went IPO on 2022-04-14. The firm is engaged in offering patented smart-safety syringe products to the healthcare industry. The firm's smart safety syringe products, such as Securgard, Sologard, and Sharps Provensa, are ultra-low waste syringes that incorporate both passive and active safety and reuse prevention features. The company Sharps Securegard and Sologard safety syringe product lines incorporate both active and passive safety features and have been designed to address the primary administration concerns with syringe delivery systems, including accidental needlestick injuries, wasted medicine/dead space and reuse prevention. The company also offers products that are designed with specialized copolymer technology to support the prefillable syringe market segment. The company has a manufacturing facility in Hungary and is pursuing plans to expand its manufacturing capacity in the United States.
What is the stock price of SHARPS TECHNOLOGY INC today?
The current stock price of STSS is 1.425 USD. The price decreased by -15.18% in the last trading session.
Does STSS stock pay dividends?
STSS does not pay a dividend.
How is the ChartMill rating for SHARPS TECHNOLOGY INC?
STSS has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Would investing in SHARPS TECHNOLOGY INC be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on STSS.
Can you provide the growth outlook for SHARPS TECHNOLOGY INC?
The Revenue of SHARPS TECHNOLOGY INC (STSS) is expected to decline by -95.06% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
Can you provide the market cap for SHARPS TECHNOLOGY INC?
SHARPS TECHNOLOGY INC (STSS) has a market capitalization of 40.23M USD. This makes STSS a Nano Cap stock.